Approvals & Mergers: Inside Enzyvant with Bill Symonds, Pharm.D.
Business Of Biotech
00:00
Ends-Event Connect for Pulmonary Artery Hypertension
The pulmonary arterial hypertension community is a bit different than the ends-event, you know, connect type community we have there. I could see us doing something similar, but more tailored to that community. And what their specific needs are obviously the patient journey and PAH is very different from the patient journey in congenital ape iMEA. It's great for people to see the end result of all of their hard work on the PAH side.
Transcript
Play full episode
